- Home
- SIMO vs BCYC Comparison
SIMO vs BCYC Comparison
Compare SIMO & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIMO
- BCYC
- Stock Information
- Founded
- SIMO 1995
- BCYC 2009
- Country
- SIMO Hong Kong
- BCYC United Kingdom
- Employees
- SIMO N/A
- BCYC N/A
- Industry
- SIMO Semiconductors
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- SIMO Technology
- BCYC Health Care
- Exchange
- SIMO Nasdaq
- BCYC Nasdaq
- Market Cap
- SIMO 2.4B
- BCYC 566.5M
- IPO Year
- SIMO 2005
- BCYC 2019
- Fundamental
- Price
- SIMO $73.47
- BCYC $8.05
- Analyst Decision
- SIMO Strong Buy
- BCYC Buy
- Analyst Count
- SIMO 8
- BCYC 10
- Target Price
- SIMO $80.63
- BCYC $25.00
- AVG Volume (30 Days)
- SIMO 309.8K
- BCYC 304.0K
- Earning Date
- SIMO 07-30-2025
- BCYC 08-05-2025
- Dividend Yield
- SIMO 2.67%
- BCYC N/A
- EPS Growth
- SIMO 59.19
- BCYC N/A
- EPS
- SIMO 2.80
- BCYC N/A
- Revenue
- SIMO $780,733,000.00
- BCYC $25,722,000.00
- Revenue This Year
- SIMO $2.23
- BCYC $7.35
- Revenue Next Year
- SIMO $13.23
- BCYC N/A
- P/E Ratio
- SIMO $26.27
- BCYC N/A
- Revenue Growth
- SIMO 10.84
- BCYC N/A
- 52 Week Low
- SIMO $37.21
- BCYC $6.10
- 52 Week High
- SIMO $82.64
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- SIMO 59.94
- BCYC 55.72
- Support Level
- SIMO $71.84
- BCYC $7.06
- Resistance Level
- SIMO $75.31
- BCYC $8.12
- Average True Range (ATR)
- SIMO 2.14
- BCYC 0.40
- MACD
- SIMO -0.42
- BCYC 0.12
- Stochastic Oscillator
- SIMO 58.65
- BCYC 95.20
About SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.